General Biotechnology

The Crystal Ball of Pharma: Using Patent Expiry Data to Build a More Accurate 3-Year Drug Spend Forecast

In the rapidly evolving landscape of pharmaceutical finance, the ability to accurately forecast drug spending is more than just a strategic advantage—it’s a necessity. Yet, many organizations still rely on traditional methods that often fall short in c…

The Crystal Ball of Pharma: Using Patent Expiry Data to Build a More Accurate 3-Year Drug Spend Forecast Read Post »

Biotechblog
Scroll to Top